Recombinant Drugs And The Economics Of Prefilled Syringes
�The administration of curative drugs via injection is an indispensable delivery method for legion drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs, and health care administration initiatives. Population demographics and efforts by managed care providers to ascendancy healthcare costs are driving the growing in dose self-administration, particularly for chronic conditions, introducing a fresh class of na�ve users to parenteral drug delivery. User-friendly syringe and injection device designs and the availability of an increasing number of drugs in pre-filled insertable and disposable cartridges are propelling the growth of prefilled syringes for self-administration.
Improved patient compliance, efficient delivery of high-priced biologicals, and affected role & health professional safety ar key securities industry drivers in this sector. The cost of biologicals such as recombinant proteins has created interest in prefilled syringes to reduce cost and waste associated with the handling and overfilling of vial-packaged drugs. Partnerships betwixt device designers and dose developers ar an essential element in the success of prefilled devices, particularly for patient self-administration.
Leading prefilled syringe applications include chronic diseases such as diabetes, autoimmune disorders, and hormone replacement. Other growth segments include procreative health and the governing of antivirals, as well as wellness programs and vaccine administration.
These findings ar contained in a new and comprehensive report: Prefilled Syringes: Drugs, Devices and Disease Therapeutics.
About Greystone
Greystone Associates is a aesculapian and healthcare technology consulting firm providing services in strategic provision, venture development, product commercialization, and technology and securities industry assessment.
Greystone Associates
More info
posted by erdemcfm42 @ 18:44
